Silver Grove Financial Group, Inc.
Position in ABT — Abbott Laboratories
CIK 2111172
ORCHARD PARK, NY
Position in ABT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$141,463
+$139,513 QoQ
Shares Held
1,559
+8105.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2,682
of 2,959 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Silver Grove Financial Group, Inc. holds $729,988 across 29 Medical Devices names. ABT ranks #2 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
451 | $141,992 | |
| 2 | ABT |
Abbott Laboratories
This page
|
1,559 | $141,463 | |
| 3 | GKOS |
GLAUKOS Corp
|
887 | $123,967 | |
| 4 | BSX |
Boston Scientific Corp
|
2,811 | $119,973 | |
| 5 | MDT |
Medtronic plc
|
1,026 | $80,263 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
447 | $28,612 | |
| 7 | EW |
Edwards Lifesciences Corp
|
195 | $17,639 | |
| 8 | SNN |
Smith & Nephew PLC
|
569 | $16,392 |
All Filings in ABT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $141,463 | 1,559 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,950 | 19 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $216,751 | 1,730 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $214,571 | 1,602 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||